fosaprepitant dimeglumine

Generic: fosaprepitant dimeglumine

Labeler: qilu pharmaceutical co., ltd.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fosaprepitant dimeglumine
Generic Name fosaprepitant dimeglumine
Labeler qilu pharmaceutical co., ltd.
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

fosaprepitant dimeglumine 150 mg/5mL

Manufacturer
Qilu Pharmaceutical Co., Ltd.

Identifiers & Regulatory

Product NDC 67184-0540
Product ID 67184-0540_62974dbd-affd-40b9-ad39-16e493f3cbec
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213106
Listing Expiration 2026-12-31
Marketing Start 2020-09-08

Pharmacologic Class

Classes
cytochrome p450 2c9 inducers [moa] cytochrome p450 3a4 inducers [moa] cytochrome p450 3a4 inhibitors [moa] neurokinin 1 antagonists [moa] substance p/neurokinin-1 receptor antagonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 671840540
Hyphenated Format 67184-0540

Supplemental Identifiers

RxCUI
1731077
UPC
0367184054015
UNII
D35FM8T64X

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fosaprepitant dimeglumine (source: ndc)
Generic Name fosaprepitant dimeglumine (source: ndc)
Application Number ANDA213106 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 150 mg/5mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (67184-0540-1) / 5 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

Ingredients (1)

fosaprepitant dimeglumine (150 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "62974dbd-affd-40b9-ad39-16e493f3cbec", "openfda": {"upc": ["0367184054015"], "unii": ["D35FM8T64X"], "rxcui": ["1731077"], "spl_set_id": ["5bb41bcb-c775-4447-9bd0-d4c55ad110ea"], "manufacturer_name": ["Qilu Pharmaceutical Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (67184-0540-1)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "67184-0540-1", "marketing_start_date": "20200908"}], "brand_name": "FOSAPREPITANT DIMEGLUMINE", "product_id": "67184-0540_62974dbd-affd-40b9-ad39-16e493f3cbec", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "67184-0540", "generic_name": "FOSAPREPITANT DIMEGLUMINE", "labeler_name": "Qilu Pharmaceutical Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FOSAPREPITANT DIMEGLUMINE", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/5mL"}], "application_number": "ANDA213106", "marketing_category": "ANDA", "marketing_start_date": "20200908", "listing_expiration_date": "20261231"}